BioCentury
ARTICLE | Company News

Invitrogen, P&G deal

November 7, 2005 8:00 AM UTC

The companies extended through December 2006 their 2001 RNAi research service deal. The companies are using IVGN's RNAi technologies for PG's target identification and validation programs. ...